Cargando…

Quality of life in patients with thalassemia major

BACKGROUND: With modern medical management, thalassemia major is now extending into adulthood and it is expected to have a negative impact on the quality of life (QOL) of the patients. The aim of this study was to evaluate quality of life in patients with thalassemia major. MATERIALS AND METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Sh, Baghersalimi, A, Azarkeivan, A, Nojomi, M, Hassanzadeh Rad, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Sadoughi University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083201/
https://www.ncbi.nlm.nih.gov/pubmed/25002926
_version_ 1782324341099200512
author Ansari, Sh
Baghersalimi, A
Azarkeivan, A
Nojomi, M
Hassanzadeh Rad, A
author_facet Ansari, Sh
Baghersalimi, A
Azarkeivan, A
Nojomi, M
Hassanzadeh Rad, A
author_sort Ansari, Sh
collection PubMed
description BACKGROUND: With modern medical management, thalassemia major is now extending into adulthood and it is expected to have a negative impact on the quality of life (QOL) of the patients. The aim of this study was to evaluate quality of life in patients with thalassemia major. MATERIALS AND METHODS: This is an analytic case control study. Two hundred and fifty patients and 51 participants as controls were assessed using WHOQOL- BREF (Farsi version) questionnaire. All questions were answered based on the self-evaluated status in the past 2 weeks before enrollment and were rated on a five-point Likert scale. Therefore, the raw item score ranged from 1 to 5 and scaled in a positive direction and 6 dimensions including overall QOL, overall health, physical, psychological, social, and environmental relationship were assessed. RESULTS: Results showed that the QOL in all 6 dimensions was lower in patients compared to the controls (P< 0.05).Also age, higher education level, lower ferritin level and using oral iron chelator were associated with better QOL scores. On the other hand, cardiac disease, hepatitis C and history of psychiatric disorders were associated with impaired QOL scores. CONCLUSION: These findings were important for future refinement of national thalassemia program. So, we recommended regular screening for psychiatric disorders and facilitated access to oral iron chelators. Regular monitoring and treatment of complications especially cardiac disease and hepatitis along with strict quality control of blood products were also mandatory. Also, higher education of the patients may improve quality of life.
format Online
Article
Text
id pubmed-4083201
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Shahid Sadoughi University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-40832012014-07-07 Quality of life in patients with thalassemia major Ansari, Sh Baghersalimi, A Azarkeivan, A Nojomi, M Hassanzadeh Rad, A Iran J Ped Hematol Oncol Original Article BACKGROUND: With modern medical management, thalassemia major is now extending into adulthood and it is expected to have a negative impact on the quality of life (QOL) of the patients. The aim of this study was to evaluate quality of life in patients with thalassemia major. MATERIALS AND METHODS: This is an analytic case control study. Two hundred and fifty patients and 51 participants as controls were assessed using WHOQOL- BREF (Farsi version) questionnaire. All questions were answered based on the self-evaluated status in the past 2 weeks before enrollment and were rated on a five-point Likert scale. Therefore, the raw item score ranged from 1 to 5 and scaled in a positive direction and 6 dimensions including overall QOL, overall health, physical, psychological, social, and environmental relationship were assessed. RESULTS: Results showed that the QOL in all 6 dimensions was lower in patients compared to the controls (P< 0.05).Also age, higher education level, lower ferritin level and using oral iron chelator were associated with better QOL scores. On the other hand, cardiac disease, hepatitis C and history of psychiatric disorders were associated with impaired QOL scores. CONCLUSION: These findings were important for future refinement of national thalassemia program. So, we recommended regular screening for psychiatric disorders and facilitated access to oral iron chelators. Regular monitoring and treatment of complications especially cardiac disease and hepatitis along with strict quality control of blood products were also mandatory. Also, higher education of the patients may improve quality of life. Shahid Sadoughi University of Medical Sciences 2014 2014-04-20 /pmc/articles/PMC4083201/ /pubmed/25002926 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ansari, Sh
Baghersalimi, A
Azarkeivan, A
Nojomi, M
Hassanzadeh Rad, A
Quality of life in patients with thalassemia major
title Quality of life in patients with thalassemia major
title_full Quality of life in patients with thalassemia major
title_fullStr Quality of life in patients with thalassemia major
title_full_unstemmed Quality of life in patients with thalassemia major
title_short Quality of life in patients with thalassemia major
title_sort quality of life in patients with thalassemia major
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083201/
https://www.ncbi.nlm.nih.gov/pubmed/25002926
work_keys_str_mv AT ansarish qualityoflifeinpatientswiththalassemiamajor
AT baghersalimia qualityoflifeinpatientswiththalassemiamajor
AT azarkeivana qualityoflifeinpatientswiththalassemiamajor
AT nojomim qualityoflifeinpatientswiththalassemiamajor
AT hassanzadehrada qualityoflifeinpatientswiththalassemiamajor